Annual Secretarial Compliance Report for the period ended 31.03.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medico Intercontinental Ltd has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, as required under SEBI Regulation 24A. The report, issued by Yash Mehta & Associates (Practicing Company Secretaries), confirms the company has complied with all applicable SEBI regulations, including the Listing Obligations and Disclosure Requirements (LODR), Insider Trading rules, and related guidelines. There were zero deviations, no penalties, and no actions taken against the company, its promoters, or directors by SEBI or stock exchanges during the review period. All related-party transactions were approved by the Audit Committee, and all event disclosures under Regulation 30 were made within prescribed timelines. No director was found disqualified under Section 164 of the Companies Act, 2013.
This is a routine, clean compliance filing with no adverse findings, penalties, or regulatory actions — a neutral event for shareholders with no expected impact on the stock price.